Helio Genomics Methylation Model Score for Early Cancer Detection Awarded as a Top Abstract for the 2024 San Antonio Liver Cancer Symposium
October 03, 2024 16:05 ET
|
Helio Genomics
IRVINE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics Appoints Eric Ariazi, Ph.D. as Chief Development Officer
August 05, 2024 08:00 ET
|
Helio Genomics
IRVINE, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics to Participate in the 2024 UBS Genomic Medicine Summit
July 24, 2024 09:00 ET
|
Helio Genomics
IRVINE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics Announces Separation from Laboratory for Advanced Medicine, a Cayman Holding Company
July 02, 2024 08:00 ET
|
Helio Genomics
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024
June 10, 2024 08:00 ET
|
Helio Genomics
IRVINE, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics to Host In-Person & Virtual KOL Event in New York to Review Results from CLiMB Pivotal Trial Presented at EASL Congress 2024 on June 17, 2024
June 06, 2024 08:00 ET
|
Helio Genomics
IRVINE, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...
Helio Genomics to Showcase Results from CLiMB Pivotal Trial in an Oral Presentation at the EASL Congress 2024
May 06, 2024 16:05 ET
|
Helio Genomics
IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer...